Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
N Engl J Med
.
2018 Sep 6;379(10):987.
doi: 10.1056/NEJMc1809065.
Authors
Robert G Hart
1
2
,
Stuart J Connolly
1
,
Hardi Mundl
3
Affiliations
1
Population Health Research Institute, Hamilton, ON, Canada
2
robert.hart@phri.ca
3
Bayer, Wuppertal, Germany
PMID:
30184459
DOI:
10.1056/NEJMc1809065
No abstract available
Publication types
Letter
Comment
MeSH terms
Anticoagulants
Atrial Fibrillation
Humans
Intracranial Embolism
Risk Factors
Rivaroxaban*
Stroke*
Substances
Anticoagulants
Rivaroxaban